Your session is about to expire
← Back to Search
Patient Only Testimonials for Diabetic Retinopathy
N/A
Waitlist Available
Led By Yao Liu, MD, MS
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre and post video testimonial intervention (up to 90 minutes)
Awards & highlights
Study Summary
This trial will involve 1,500 Latinx patients with diabetes participating in an online survey and 20 patients in 4 focus groups. The study aims to gather initial information on how patient and clin
Who is the study for?
This trial is for Latinx individuals with diabetes. It aims to gather data on whether video testimonials can improve their understanding of eye health and trust in healthcare.Check my eligibility
What is being tested?
The study involves an online survey and focus groups to evaluate the impact of patient and clinician video testimonials on diabetic eye screening education among Latinx communities.See study design
What are the potential side effects?
Since this trial involves non-invasive methods like surveys and educational videos, there are no direct physical side effects expected from participation.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ pre and post video testimonial intervention (up to 90 minutes)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre and post video testimonial intervention (up to 90 minutes)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Eye Health Literacy as measured by Compliance with Annual Diabetic Eye Exams Survey (CADEES)
Secondary outcome measures
Change in Trust in Healthcare as measured by Trust in the Health Care Team (T-HCT) scale score
Trial Design
5Treatment groups
Active Control
Group I: Patient Only TestimonialsActive Control1 Intervention
Group II: National Eye Institute video ControlActive Control1 Intervention
Group III: Patient plus Clinician Combined TestimonialsActive Control1 Intervention
In addition to being randomized for online survey participants, focus groups will view patient plus clinician combined testimonials.
Group IV: Clinician Only TestimonialsActive Control1 Intervention
Group V: Pre-video questionnaire-only ControlActive Control1 Intervention
Find a Location
Who is running the clinical trial?
University of Wisconsin, MadisonLead Sponsor
1,191 Previous Clinical Trials
3,168,170 Total Patients Enrolled
5 Trials studying Diabetic Retinopathy
8,246 Patients Enrolled for Diabetic Retinopathy
National Eye Institute (NEI)NIH
547 Previous Clinical Trials
1,400,631 Total Patients Enrolled
50 Trials studying Diabetic Retinopathy
41,419 Patients Enrolled for Diabetic Retinopathy
Yao Liu, MD, MSPrincipal InvestigatorUniversity of Wisconsin, Madison
2 Previous Clinical Trials
2,010 Total Patients Enrolled
2 Trials studying Diabetic Retinopathy
2,010 Patients Enrolled for Diabetic Retinopathy
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are researchers currently recruiting participants for this ongoing clinical trial?
"The ongoing trial, as per clinicaltrials.gov, is not actively enrolling participants. It was initially listed on September 1st, 2024 and last modified on February 5th, 2024. Although this specific trial is not recruiting subjects presently, there are currently 63 other trials open for enrollment."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger